Aktie 633407 EXTRAWELL PHARMACEUTICAL HOLDINGS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Extrawell Pharmaceutical Holdings Limited

Aktien

633407

BMG3285Q1134

858

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:08:28 24.05.2024 		% 5 Tage % 1. Jan.
0.038 HKD -2.56% Intraday Chart für Extrawell Pharmaceutical Holdings Limited -5.00% +11.76%
2023 Extrawell Pharmaceutical erleidet im ersten Halbjahr des Geschäftsjahres einen Verlust aufgrund von Marktwertverlusten MT
2023 Extrawell Pharmaceutical Holdings Limited berichtet über die Ergebnisse für das Halbjahr bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Extrawell Pharmaceutical Swings to Fiscal H1 Loss on Fair Value Losses
Extrawell Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023
Extrawell Pharmaceutical Holdings Forecasts Swing to Loss in Fiscal H1; Shares Fall 3%
Extrawell Pharmaceutical Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 September 2023
Extrawell Pharmaceutical Amends Terms of Convertible Bonds by Innovative Pharmaceutical Biotech
Extrawell Pharmaceutical's Fiscal Year 2023 Attributable Profit Falls
Extrawell Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Extrawell Pharmaceutical Unit Completes Share Buyback Deal
Extrawell Pharmaceutical to Swing to Loss in FY23
Extrawell Pharmaceutical Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 March 2023
Extrawell Pharmaceutical Holdings Limited Appoints Guo Yi as an INED of the Company, and A Member of Each of the Audit Committee, Remuneration Committee and Nomination Committee of the Board with Effect from 14 April 2023
Extrawell Pharmaceutical Holdings Limited Announces Demise of Mr. Xue Jing Lun, Independent Non-Executive Director, and A Member of Each of the Audit Committee, Remuneration Committee and Nomination Committee
Extrawell Pharmaceutical's Profit for Six Months Through September Nearly Halves
Extrawell Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2022
Extrawell Pharmaceutical Forecasts Decline in Fiscal H1 Profit
Extrawell Pharmaceutical Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 September 2022
Extrawell Pharmaceutical Holdings Limited Announces Management Changes
Extrawell Pharmaceutical Holdings Swings to Profitability in FY22
Extrawell Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2022
Extrawell Pharma Sees Profit Surge in FY22
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 633407 Aktie
  4. Nachrichten Extrawell Pharmaceutical Holdings Limited
  5. Andere Sprachen